Cutting edge products demand more stringent controls

Today’s pharmaceutical industry test professionals are looking for the latest information on sterile manufacturing as the development of new biopharmaceuticals have led to injectable product manufacturing, which requires faster, more stringent microbiological controls.

Test professionals can hear the latest on the subject at Pharma Test Expo 2011, to be held next February 8-10, in Cologne, Germany.Dr Tim Sandle will speak on “Practical approaches to sterility testing” at the Pharma Test Expo 2011 Forums, where research and industry experts will be sharing the latest developments in the field of testing and quality assurance for pharmaceuticals.

Dr Sandle is the Head of Microbiology at the UK National Health Service Bio Products Laboratory. He is co-editor of the new book, Microbiology and Sterility Assurance in Pharmaceuticals and Medical Devices, which has been called “The gold standard for sterile manufacturing.”

Dr Sandle’s presentation will look at general difficulties associated with sterility test validation; consider practical approaches to products which are difficult to test; and provide an overview of those aspects of the sterility test which are not covered in the pharmacopoeias, along with current debates about the sterility test. Both the membrane filtration and direct inoculation methods will be covered.

Pharma Test Expo 2011 will be the forum of reference for the suppliers and users of pharmaceutical test equipment, instrumentation and outsourced services in the product development and manufacturing process. Don’t miss the chance to see and hear the latest at the first fair dedicated exclusively to testing and quality assurance in the pharmaceuticals industry.

Pharma Test Expo
8,9, 10 February 2011
Koelnmesse, Cologne, Germany

Contact
David Stradling
Direct Tel: +44 (0) 1306 803032
Fax: +44 (0) 1306 803034
Email: d.stradling@hulst-expo.comhttp://www.pharmatestexpo.com/